Physician profile
Michael A Codina
NPI 1871540708
$3,252.81
in general payments reported to CMS, 2019-2025
17 companies · $323 in 2025
The $323 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $502 · 2020: $459 · 2021: $740 · 2022: $931 · 2023: $216 · 2024: $82.07 · 2025: $323.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $621.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $620.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,424.14 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $665.10 | 2019-2025 | Camzyos, Eliquis |
| Actelion Pharmaceuticals US, INC. | $282.21 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $239.95 | 2019-2025 | |
| Pfizer INC. | $222.16 | 2019-2025 | |
| Amarin Pharma, INC. | $109.32 | 2020 | |
| Irhythm Technologies, INC. | $82.59 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $59.34 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $30.86 | 2021-2023 | Farxiga |
| Novo Nordisk INC | $26.07 | 2025 | Wegovy |
| Lantheus Medical Imaging, INC. | $22.12 | 2021 | |
| Amgen INC. | $17.04 | 2022 | |
| Lilly USA, LLC | $17.01 | 2025 | Zepbound, Mounjaro |
| Biotronik INC. | $16.74 | 2020 | |
| Boston Scientific Corporation | $14.96 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $11.98 | 2025 | Lifevest |
| United Therapeutics Corporation | $11.22 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Codina listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.